Submit Buy Request
View Synopsis & Table of contentThe U.S. Interventional Oncology market is booming, reaching $6.5 billion in 2025 and projected to grow at a CAGR of 7.8% through 2033. Driven by advancements in minimally invasive procedures like ablation and embolization, this market caters to the rising prevalence of lung, liver, and kidney cancers. Learn more about market trends, key players, and growth projections.
Total Amount: $2850
Our Clients
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
Key Highlights of Report
Mar, 2025
150
Tables
Base Year: 2024.
Coverage: 18 Countries
Companies: 15+
Connect With us
